What the Study Found (In Plain English)
Published in The Journal of clinical endocrinology and metabolism (2016), this randomized controlled trial evaluating 198 human participants investigated: To determine the contributions of testosterone and estradiol deficiency to VMS in hypogonadal men. Key clinical takeaway: Estradiol deficiency is the key mediator of VMS in hypogonadal men. At high levels, testosterone may have a suppressive effect.
Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers
Primary Endpoint & Quantitative Summary (The Journal of clinical endocrinology and metabolism, 2016-09-15; N = 198; Rigor 88/100): Estradiol deficiency is the key mediator of VMS in hypogonadal men. At high levels, testosterone may have a suppressive effect.
Study Limitations & Caveats Before You Act
Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.